VHIO’s multidisciplinary teams collaborate through dedicated Task Forces (TFs), coordinated by VHIO’s Scientific Management Area, to align research initiatives with the institute’s strategic vision and core priorities. These teams are designed to foster interaction among professionals from various oncology-related fields, including preclinical and translational researchers, clinical investigators, medical oncologists, pathologists, specialists from different medical disciplines, clinical research nurses, data specialists, study coordinators, and project managers.

Each TF focuses on a specific area of cancer research and is structured to facilitate collaboration among specialists involved in study development and management. Currently, our TFs cover multiple tumor types, including breast, colorectal, gastroesophageal, neuroendocrine, rectal, pancreatic, and biliary tract cancers, among others. Additionally, there are transversal TFs dedicated to strategic areas such as oncology imaging and patient engagement in research, ensuring a comprehensive approach to both clinical and scientific challenges in oncology.

Throughout 2024, VHIO has worked to strengthen and expand its TFs to enhance their impact and efficiency. As part of this effort, some TFs such as those dedicated to prostate and renal cancers have been reactivated. Moreover, within the colorectal cancer TF, new working groups have been established to focus on specific areas of clinical and translational interest, including BRAF-mutated tumors, liver metastases (LiverMets), and early-onset colorectal cancer. These working groups aim to refine research strategies and improve the development of targeted therapeutic approaches. A transversal Working Group about liquid biopsy has been established during this year.

Each TF is led by an appointed Chair and supported by a project manager responsible for ensuring smooth coordination. Their role includes setting meeting agendas, compiling minutes, following up on action points, and fostering synergies across VHIO’s TFs. The structure and activity level of each TF vary depending on their size, workflow, and participant engagement. This flexible and adaptive structure allows VHIO’s TFs to continuously evolve and address emerging research needs.

VHIO’s TFs also serve as a platform for fostering collaborative research across institutions. Clinical investigators from Vall d’Hebron and other hospitals in Catalonia, along with translational researchers from the Vall d’Hebron Barcelona Hospital Campus and other research centers, actively contribute to these initiatives, promoting multidisciplinary collaboration and knowledge exchange.

Looking ahead to 2025, VHIO aims to further strengthen its existing TFs while optimizing their structure to enhance operational efficiency. Some TFs may be restructured to better align with evolving research needs, ensuring they continue to drive progress in precision oncology and maximize their impact on patient care and clinical research.